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（ ）1.经厦门大学保密委员会审查核定的保密学位论文，于  
































个 MSC 的 DMEM 混悬液，左眼相同部位注射同样体积的 DMEM 培养基作为




印迹检测（VEGF、III 型胶原、Notch1）。为了探究不同免疫状态对 MSC 命运
及对周围组织的影响，选取经 4GyX 线照射大鼠及裸大鼠进行 MSC 角膜缘注
射，注射方法及细胞量同前，注射后第 3、6、9 及 12 天，进行裂隙灯照相观察
结膜充血水肿情况，然后处死实验动物并进行以上检测。为验证 MSC 对损伤
的修复作用，选取雄性健康 SD 大鼠建立角膜缘损伤模型，然后于角膜缘球结
膜下注射 50μl 含 2╳105 个 MSC 的 DMEM 混悬液，左眼注射同样体积的
DMEM 培养基做为对照组。注射后 6 天内每天观察角膜上皮修复情况、新生血
管形成及结膜充血情况。 
结果：采用改良的酶消化法对脐带进行分离培养可得到形态良好、增殖能力强
的 MSC，流式细胞学鉴定符合现有标准。MSC 注射后第 6 天角膜缘球结膜可
见轻度充血；HE 染色显示结膜下细胞团逐渐缩小，伴有少量炎症细胞浸润，注
射区域角膜缘结膜上皮轻度增厚，以注射后第 6 天较为明显；人 Vimentin 免疫
荧光染色显示 MSC 注射后阳性细胞逐渐减少，第 9 天完全消失，且并未转移
















皮基底层细胞 K14 染色增强，均以第 3 天及第 6 天较明显；TUNEL 与
Vimentin 双重染色可见，Vimentin 阳性细胞中可见多量 TUNEL 阳性细胞，随
着观察时间的延长逐渐减少；流式细胞学检测结膜中 CD45 及 CD11b 比例轻度
升高，第 9 天达到高峰，而后逐渐降低至正常；Real-Time PCR 结果显示促炎
因子及抑炎因子的表达均有升高，且幅度相当，多种生长因子及 I、II、III 型胶
原均在第 3 天及第 6 天明显升高；ELISA 及蛋白印迹结果与 PCR 基本一致。
MSC 注射到 X 线照射大鼠及裸大鼠角膜缘球结膜下，未引起明显炎症反应，
Vimentin 与 Ki67 染色结果显示，MSC 在 X 线照射大鼠角膜缘结膜下可存活 9
天，在裸大鼠中可存活 12 天，Vimentin 阳性细胞的 Ki67 表达阴性，但
Vimentin 阳性细胞周围结膜中仍可见多量 Ki67 阳性细胞，Real-Time PCR 显示
X 线照射大鼠结膜中的炎症因子轻度升高，而裸大鼠的持续正常水平，但两者
结膜中多种生长因子及胶原的表达均明显增加。将 MSC 角膜缘球结膜下注射
于角膜缘损伤大鼠，第 2 天即可观察到 MSC 组角膜上皮缺损面积明显较对照
组小，角膜缘处可见长度约 1~2mm 新生血管侵入角膜，到第 4 天所有大鼠的角
膜上皮恢复完整，MSC 组新生血管已全部消退，整个过程中大鼠球结膜并未出
现明显充血。 
结论：MSC 角膜缘球结膜下注射后能存活约 9~12 天，并未发生增殖、转移及


















Purpose:  Mesenchymal stem cell (MSC)-based therapy has been proposed as a 
therapeutic strategy for ocular surface diseases over a decade. Previous studies mainly 
focused on their therapeutic effects on corneal wound healing, while the fate of MSCs 
and their effect on the local microenvironment remains unknown. In this study, we used 
rat models to investigate the survival, migration, proliferation, differentiation and 
paracrine functions of human umbilical cord mesenchymal stem cells, as well as their 
impact on the limbal microenvironment after limbal injection. Further more, we 
observed the effect of MSCs injection on limbal wound healing. 
Material and methods: MSCs were isolated from neonatal umbilical cord by 
collagenase and hyaluronidase digestion and characterized by flow cytometry. Sprague-
Dawley rats were subjected to MSCs subconjunctival injection close to the limbal area. 
For each rat, the right eye was injected with 2X105 MSCs suspended in DMEM, and 
the left eye was administered an equal amount of DMEM as control. On the 3rd, 6th 9th 
and 12th day after injection, the rats were examined under slit-lamp microscope to 
evaluate the conjunctival edema and hyperemia. After that the rats were sacrificed, 
double-immunofluorescence was performed to investigate the expression of Vimentin, 
α-SMA and Ki-67. TUNEL assay was performed to evaluate cell apoptosis. CD11b or 
CD45 positive cells in conjunctiva were quantified by flow cytometry. Furthermore, 
Real-Time PCR, ELISA or Western blot was applied to detect cytokines, collagens and 
Notch and BMP signaling pathway related proteins. In order to investigate the fate of 
MSCs and their injection related changes in the local microenvironment in rats with 
different immune status, the X-ray exposed rats and nude rats were subjected to MSCs 
limbal injection. On the 3rd, 6th 9th and 12th day after injection, the rats were examined 
under slit-lamp microscope. After that, the rat were sacrificed, and immunostaining, 
TUNEL and Real-Time PCR was examined as above. In order to confirm the 















model was established and subjected to MSCs limbal injection. On the 3rd, 6th, 9th and 
12th day after injection, the corneal epithelium defect, conjunctival hyperemia and 
neovascularization was evaluated.  
Results: MSCs were isolated according to their ability to adhere to cell culture plastic 
plates. Flow cytometry analysis results met the basic criterion. At the injection site, rat 
conjunctiva showed mild hyperemia on day 6 and vanished gradually. HE staining 
showed that limbal cell mass gradually reduced, with a small amount of immune cell 
infiltration and conjunctival epithelial hyperplasia of the injection area. All the injected 
cells remained in the same region as they had originally been engrafted, and none of 
them could be detected in the injured cornea and other tissues, suggesting no cell 
migration. The majority of MSCs survived till day 6 after injection.  However, the cell 
mass gradually decreased, and disappeared on day 9 after injection. Using human 
specific vimentin as a marker, we could observe quite a few Ki67 positive cells 
surrounding the vimentin+ cell mass, while the Ki67 positive cells were undetectable 
within the injected cell mass. Immuno-staining against α-SMA was negative from day 
3 to day 12. In addition, K14 expression in limbal basal epithelium was stronger on day 
3 to day 6 than control group. TUNEL positive cells were present in the injected cell 
mass and reduced gradually. Compared with the control eyes, the quantities of CD11b+ 
and CD45+ cells were increased slightly in the injected eyes, which gradually reduced 
to normal basal levels on day 12. The mRNA expression levels of pro-inflammatory 
and anti-inflammatory factors were both up-regulated. The expression of growth factors 
such as KGF, EGF, SDF-1α, collagen, Notch1, HES-1 and BMP4 increased on day 3 
and day 6 after injection. ELISA and Western blot results also supported the Real- Time 
PCR results. For the X-ray exposed rat and nude rat, the conjunctiva showed no 
hyperemia at the injection site. Double immunofluorescent staining against vimentin 
and Ki67 showed that there were Ki67 positive cells surrounding the vimentin positive 
cell mass, though no Ki67 positive cells inside the cell mass. Vimentin positive cells 
vanished on day 9 in X-ray exposed rat and day12 in nude rat. The mRNA expression 















injection, while no difference between nude rats with or without MSCs injection. The 
expression of growth factors and collagen is up-regulated dramatically in X-ray 
exposed rats and nude rats with MSCs injection. For limbal injury rats, the recovery of 
the corneal surface was significantly faster in the MSC group than control group on day 
2 after limbal injection. Compared to the control group, there was 1~2mm corneal 
neovascularization after MSCs injection. On day 4, corneal epithelium was completely 
healed and the new blood vessels were regressed. 
Conclusions: MSCs could survive for 9 to 12 days after limbal injection and gradually 
eliminated from the injection site without cell migration, proliferation and 
differentiation. The microenvironment was altered through paracrine function, slight 
inflammatory stimulus and the activation of Notch and BMP signaling pathways. MSCs 


















中文摘要 .................................................................................................... I 
ABSTRACT ............................................................................................ III 
目录.......................................................................................................... VI 
Table of Contents ................................................................................... IX 
第一章 前言 .............................................................................................. 1 
1.1 间充质干细胞概述 ............................................... 1 
1.1.1 MSC 的概念及来源............................................................................................. 1 
1.1.2 MSC 的分化潜能................................................................................................. 1 
1.1.3 MSC 的免疫特性................................................................................................. 1 
1.1.4 MSC 的原代培养................................................................................................. 2 
1.1.5 MSC 的鉴定......................................................................................................... 2 
1.1.6 MSC 的标记......................................................................................................... 2 
1.2 间充质干细胞用于角膜重建的研究进展 ............................ 3 
1.2.1 MSC 在眼科治疗的应用方法............................................................................. 3 
1.2.2 MSC 的转分化作用............................................................................................. 3 
1.2.3 MSC 的抗炎作用................................................................................................. 5 
1.2.4 MSC 调节新生血管的作用................................................................................. 6 
1.2.5 MSC 在角膜修复中的作用................................................................................. 6 
1.2.6 MSC 与器官移植................................................................................................. 7 
1.3.角膜缘微环境（niche） ......................................... 8 
1.4 角膜缘微环境相关疾病 .......................................... 8 
1.5 角膜上皮干细胞微环境的体内重建与体外模拟 ....................... 9 
1.5.1 角膜上皮干细胞微环境的体内重建................................................................. 9 
1.5.2 角膜上皮干细胞微环境的体外模拟................................................................. 9 
1.6 间充质干细胞对角膜缘干细胞或角膜缘微环境的影响 ................ 10 
1.7 研究意义 ..................................................... 10 
1.8 技术路线 ..................................................... 11 
1.8.1 MSC 的分离培养与鉴定................................................................................... 11 
1.8.2 MSC 在大鼠角膜缘球结膜下注射后的命运及对角膜缘微环境的影响....... 11 
1.8.3 角膜缘球结膜下注射 MSC 促进上皮修复及新生血管形成.......................... 12 
第二章 实验材料与方法 ........................................................................ 13 
2.1 实验材料 ..................................................... 13 
2.1.1 脐带.................................................................................................................. 13 















2.1.3 主要化学试剂与耗材...................................................................................... 13 
2.1.4 主要抗体.......................................................................................................... 15 
2.1.5 主要仪器.......................................................................................................... 16 
2.1.6 主要溶液配制.................................................................................................. 17 
2.2 实验方法 ..................................................... 23 
2.2.1 人脐带间充质干细胞(MSC)原代及传代培养................................................ 23 
2.2.2 流式细胞仪鉴定间充质干细胞...................................................................... 24 
2.2.3 正常 SD 大鼠球结膜下注射间充质干细胞.................................................... 24 
2.2.4 角膜缘损伤大鼠球结膜下注射间充质干细胞.............................................. 25 
2.2.5 大鼠眼球冰冻切片的制备.............................................................................. 26 
2.2.6 HE 染色............................................................................................................. 26 
2.2.7.免疫荧光染色（双重染色）.......................................................................... 27 
2.2.8 细胞凋亡染色（TUNEL 染色+Vimentin 双重染色）.................................... 28 
2.2.9 注射后大鼠结膜组织炎症细胞流式细胞检测.............................................. 29 
2.2.10 结膜组织 mRNA 的提取与逆转录.................................................................. 30 
2.2.11 实时定量 PCR（Real-Time PCR）............................................................... 32 
2.2.12 蛋白印迹实验................................................................................................ 32 
2.2.13 ELISA.............................................................................................................. 36 
第三章 实验结果 .................................................................................... 40 
3.1 人脐带间充质干细胞（MSC）的原代培养与流式鉴定 ................. 40 
3.1.1 原代培养 MSC 形态观察.................................................................................. 40 
3.1.2 原代培养 HUMSC 的流式鉴定.......................................................................... 41 
3.2 MSC 在正常大鼠角膜缘球结膜下注射后的命运 ...................... 41 
3.2.1 MSC 在正常大鼠角膜缘球结膜下注射后的局部表现................................... 41 
3.2.2 MSC 在正常大鼠角膜缘球结膜下注射后的增殖情况................................... 42 
3.2.3 MSC 在正常大鼠角膜缘球结膜下注射的存活及迁移................................... 43 
3.2.4 MSC 在正常大鼠角膜缘球结膜下注射后的分化情况................................... 45 
3.3 MSC 在正常大鼠角膜缘球结膜下注射后对周围组织及角膜缘微环境的影响
 ................................................................. 46 
3.3.1 MSC 在正常大鼠角膜缘球结膜下注射后对结膜上皮的影响....................... 46 
3.3.2 MSC 在正常大鼠角膜缘球结膜下注射后对角膜缘的影响........................... 47 





3.3.6 MSC 在正常大鼠角膜缘球结膜下注射后刺激结膜组织胶原表达改变....... 55 
3.3.7 MSC 在正常大鼠角膜缘球结膜下注射后刺激结膜组织 Notch 及 BMP 信号
通路激活...................................................................................................................... 57 
3.4 不同免疫状态下的大鼠对角膜缘球结膜下注射的 MSC 的反应 .......... 58 
3.4.1 MSC 在 X 线照射大鼠及裸大鼠角膜缘球结膜下注射后的局部表现及 HE 染
色.................................................................................................................................. 58 
















3.4.3 MSC 在 X 线照射大鼠及裸大鼠角膜缘球结膜下注射后引起的局部炎症反
应.................................................................................................................................. 61 
3.4.4  MSC 在 X 线照射大鼠及裸大鼠角膜缘球结膜下注射后刺激局部结膜组织
生长因子表达的改变.................................................................................................. 62 
3.4.5  MSC 在 X 线照射大鼠及裸大鼠角膜缘球结膜下注射后刺激局部结膜组织
胶原表达的改变.......................................................................................................... 63 
3.5 角膜缘球结膜下注射 MSC 促进大鼠角膜缘损伤模型的上皮修复及新生血管
形成 ............................................................. 64 
第四章 讨论 ............................................................................................ 66 
4.1 MSC 来源的选取 ................................................ 67 
4.2 MSC 分离培养的方法及鉴定的选择 ................................ 67 
4.3 实验动物及动物模型的选取 ...................................... 68 
4.4 MSC 角膜缘球结膜下注射后的命运 ................................ 69 
4.4.1 MSC 角膜缘球结膜下注射后的存活 ............................................................... 69 
4.4.2 MSC 角膜缘球结膜下注射后的迁移 ............................................................... 70 
4.4.3 MSC 角膜缘球结膜下注射后的增殖 ............................................................... 71 
4.4.4 MSC 角膜缘球结膜下注射后的分化 ............................................................... 71 
4.5 MSC 角膜缘球结膜下注射后对角膜缘微环境的影响 ................... 72 
4.5.1 MSC 角膜缘球结膜下注射后引起的炎症反应 ............................................... 72 
4.5.2 MSC 角膜缘球结膜下注射后的旁分泌作用及对周围组织的影响 ............... 73 
4.5.3 MSC 角膜缘结膜下注射后引起结膜 Notch 及 BMP 信号通路的改变 ........... 74 
4.6 MSC 角膜缘球结膜下注射促进角膜上皮修复及新生血管形成 ........... 75 
第五章 全文总结 .................................................................................... 76 















Table of Contents 
IX  
Table of Contents 
Abstract in Chinese ................................................................................... I 
Abstract in English ................................................................................ III 
Table of Contents in chinese ................................................................. VI 
Table of Contents in English ................................................................. IX 
Chapter 1 Introduction ............................................................................ 1 
1.1 The introduction of mesenchymal stem cells(MSC) ..................... 1 1.1.1 The concept and the source of MSC ..................................................................... 1 1.1.2 The differentiated potential of MSC  ................................................................... 1 1.1.3 The immunological characteristics of MSC.......................................................... 1 1.1.4 The primary culture of MSC ................................................................................. 2 1.1.5 The identification of MSC .................................................................................... 2 1.1.6 The tag of MSC  ................................................................................................... 2 1.2 The deveolpment of MSC used in the ocular surface reconstruction reserach 
 .................................................................. 3 1.2.1 The methods of MSC treatment in ophthalmology  .............................................. 3 1.2.2 The transdifferentiation of MSC  ......................................................................... 3 1.2.3 The  anti-inflammatory effect of MSC ........................................................................ 5 1.2.4 The effect of MSC on neovascularization .................................................................. 6 1.2.5 The effect of MSC on corneal wound healing MSC ............................................. 6 1.2.6 MSC and organ transplantation ............................................................................ 7 1.3 Limbal stem cell niche ............................................ 8 1.4 The limbal stem cell diseases ....................................... 8 1.5 The in vivo reconstruction and the in vitro mimic of the limbal stem cell niche 













Table of Contents 
X  
Chapter Two Materials and methods .................................................... 13 
2.1 Materials  ..................................................... 13 2.1.1 The umbilical cord  ............................................................................................ 13 2.1.2 Laboratory animals ............................................................................................. 13 2.1.3 Regents and consumptive materials .................................................................... 13 2.1.4 Antibodies  ......................................................................................................... 15 2.1.5 Equipment ........................................................................................................... 16 2.1.6 The preparation of regents .................................................................................. 17 2.2 Methods ................................................................................................................. 23 2.2.1 The primary culture and passage of MSC  ......................................................... 23 2.2.2 The identification of MSC by flow cytometry analysis  .................................... 24 2.2.3 The MSC limbal injection in normal rats   ....................................................... 24 2.2.4 The MSC limbal injection in rats with limbal stem cell injury  ......................... 25  2.2.5 The preparation of rat eye balls frozen section ................................................... 26 2.2.6 HE staining.......................................................................................................... 26 2.2.7.Double immunofluorescence staining ............................................................... 27 2.2.8 TUNEL ............................................................................................................... 28 2.2.9 Flow cytometry analysis of inflammtory factors in conjunctival tissues after MSC limbal injection  ................................................................................................. 29 2.2.10 RNA isolation, reverse transcription and quantitative real time PCR of conjunctiva tissues ....................................................................................................... 30 2.2.11 Real-Time PCR  ............................................................................................... 31 2.2.12 Western blot ...................................................................................................... 32 2.2.13 ELISA ............................................................................................................... 36 
Chapter Three Results ........................................................................................ 40 
3.1 The primary culture of MSC and the identificaion by flow cytometry .......... 40 3.1.1 The morphology of primary cultured MSC ........................................................ 40 3.1.2 Flow cytometry analysis of primary cultured MSC ............................................ 41 3.2 The fate of MSC after injected into normal rats subconjuctiva .......... 41 3.2.1 The morphology of ocular surface and HE staining of normal rats after MSC limbal injection ............................................................................................................ 41 
3.2.2 The proliferation of MSC after limbal injection in normal SD rat 
  .................................................................................................................................. 42 3.2.3 The survival and migration of MSC after limbal injection in normal rat   .................................................................................................................................. 43 
3.2.4 The differentiation of MSC after limbal injection in normal rat 













Table of Contents 
XI  
3.3.2 The affect of MSC on limbal epithelium after limbal injection in normal rat…47 3.3.3 The affect of MSC on the proliferation of native conjunctival stroma cells after limbal injection in normal rat……………………………………………………………………………………………….49  
3.3.4 Flow cytometry analysis of infiltrated inflammatory cells in local conjunctiva 
after limbal injection in normal rat……………………………………………………50 
3.3.5 The paracrine function of MSC and the change of growth factors in surrounding native conjunctival tissues after limbal injection in normal rats……………………..53  3.3.6 The change of collagen expression in the conjuntival tissues of normal rats after MSC limbal injection MSC ......................................................................................... 55 3.3.7 The activation of Notch and BMP signaling pathways after MSC limbal injection........................................................................................................................ 57 3.4 The response of MSC limbal injection in rats under different inflammatory situations  ........................................................ 58 
3.4.1 The morphology of ocular surface and HE staining of X-ray exposed and nude 
rats after MSC limbal injection………………………………………………………58 
3.4.2 The affect of MSC on surrounding native tissues after limbal injection ............ 59 3.4.3 The stimulation of inflammatory effect after MSC limbal injection .................. 60 3.4.4 The change of growth factors level in the conjunctival tissues of X-ray exposed and nude rats after MSC limbal injection   ................................................................ 61 3.4.5 The change of collagen expression in the conjuntival tissues of X-ray exposed and nude rats after MSC limbal injection .................................................................... 63 3.5 The epithelial wound healing and neovascularization after MSC limbal injection in rats with limbal stem cell deficiency ......................... 64 
Chapter Four Discussion ........................................................................ 66 
4.1 The selection of MSC source  ..................................... 67 4.2 The choose of MSC isolation and identificaion methods ................ 67 4.3 The choose of experimental animals and animal models ................ 68 4.4 The fate of MSC after limbal injection ............................. 69 4.4.1 The survival of MSC after limbal injection   .................................................... 69 4.4.2 The migration of MSC after limbal injection  ................................................... 70 4.4.3 The proliferation of MSC after limbal injection ................................................. 70 4.4.4 The differentiation of MSC after limbal injection .............................................. 70 4.5 The affect of MSC on limbal stem cell niche after limbal injection  ..... 71 4.5.1 The stimulation of  inflammatory effect after limbal injection …… ................. 71 4.5.2 The affect of MSC on paracrine function and surrounding native tissues after limbal injection ............................................................................................................ 73 4.5.3 The change of Notch and BMP signaling pathways after MSC limbal injection ...   ................................................................................................................................... 74 4.6 The promotion of wound healing and neovascularization of corneal epithelium after MSC limbal injection   ............................... 75 













Table of Contents 
XII  







































































1.1.3 MSC 的免疫特性 
MSC 具有低免疫原性，以往认为是由于 MSC 在无任何刺激情况下细胞表
面低表达主要组织相容性抗原 II 类分子（MHC II），不表达一些共刺激分子，
如 CD40，CD40L，B71，B72[16]。但有体外实验表明，将 MSC 混合在淋巴细胞
中共同培养，即使加入干扰素 γ 诱导 MSC 表达完整的 MHCII 分子，仍未见免
疫应答，且在混合细胞反应中提供 CD40，CD40L，B71，B72 等共刺激因子后，
未能引起免疫应答。提示 MSC 的低免疫原性可能与 MHCs 分子及共刺激分子表
达无关，而与 MSC 对免疫细胞的直接抑制作用及分泌相关因子形成免疫抑制微
环境有关。也有动物实验将经体内扩增的 HLA 相合供者或第三者来源的 MSC
输入动物体内后，未发生免疫排斥反应，且能显著延长移植器官存活时间，提
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